BRCAness in Prostate Cancer

Oncotarget - United States
doi 10.18632/oncotarget.26818
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Androgen Receptor Inhibitor–induced “BRCAness” and PARP Inhibition Are Synthetically Lethal for Castration-Resistant Prostate Cancer

Science Signaling
BiochemistryCell BiologyMolecular Biology
2017English

BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence

PLoS ONE
Multidisciplinary
2012English

Immunotherapy in Prostate Cancer

The Bulletin of Urooncology
2019English

Epigenetics in Prostate Cancer

Prostate Cancer
Cancer ResearchOncologyUrology
2011English

Prostate Cancer

Nature
Multidisciplinary
2015English

Prostate Cancer

British Journal of Cancer
Cancer ResearchOncology
2003English

Does Screening for Prostate Cancer Reduce Prostate Cancer Mortality?

Canadian Urological Association Journal
Urology
2013English

Prostate Arterial Chemoembolization for Prostate Cancer

Journal of Vascular and Interventional Radiology
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2017English

Zinc Transporters in Prostate Cancer

Molecular Aspects of Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy